Quantitative in vivo receptor binding III: Tracer kinetic modeling of muscarinic cholinergic receptor binding.

nork Frey, K A, Hichwa, R D, Ehrenkaufer, R L, Agranoff, B W
Argitaratua 1985

Striatal [(11)C]dihydrotetrabenazine and [(11)C]methylphenidate binding in Tourette syndrome

nork Albin, R L., Koeppe, R A., Wernette, K, Zhuang, W, Nichols, T, Kilbourn, M R., Frey, K A.
Argitaratua 2009

Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease

nork Ridder, A., Müller, M.L.T.M., Kotagal, V., Frey, K.A., Albin, R.L., Bohnen, N.I.
Argitaratua izan da Parkinsonism Relat Disord (2016)

History of falls in Parkinson disease is associated with reduced cholinergic activity

nork Bohnen, N I., Müller, M L.T.M., Koeppe, R A., Studenski, S A., Kilbourn, M A., Frey, K A., Albin, R L.
Argitaratua 2009

Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options

nork Ludolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E.-M., Burn, D. J., Caparros-Lefebvre, D., Frey, K. A., de Yebenes, J. G., Gasser, T., Heutink, P., Höglinger, G., Jamrozik, Z., Jellinger, K. A., Kazantsev, A., Kretzschmar, H., Lang, A. E., Litvan, I., Lucas, J. J., McGeer, P. L., Melquist, S., Oertel, W., Otto, M., Paviour, D., Reum, T., Saint-Raymond, A., Steele, J. C., Tolnay, M., Tumani, H., van Swieten, J. C., Vanier, M. T., Vonsattel, J.-P., Wagner, S., Wszolek, Z. K.
Argitaratua 2009